{"title_page": "Hemicholinium-3", "text_new": "{{Redirect|HC-3|the United States Navy helicopter squadron designated HC-3 from 1967 to 2005|HCS-3}}\n{{Drugbox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 400103507\n| IUPAC_name = (2''S'',2''S'')-2,2'-biphenyl-4,4'-diyl''bis''(2-hydroxy-4,4-dimethylmorpholin-4-ium)\n| image = Hemicholinium-3.svg\n| alt = Skeletal formula\n| width = 260\n| image2 = Hemicholinium-3 cation spacefill.png\n| alt2 = Space-filling model of the hemicholinium-3 cation\n\n<!--Clinical data-->\n| tradename =  \n| legal_status =  \n| routes_of_administration =\n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =\n\n<!--Identifiers-->\n| IUPHAR_ligand = 4493\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 312-45-8\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 65NY3I7ZD0\n| ATC_prefix = None\n| ATC_suffix =  \n| PubChem = 9399\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 9029\n| ChEMBL_Ref = {{ebicite|changed|EBI}}\n| ChEMBL = 268697\n\n<!--Chemical data-->\n| C=24 | H=34 | N=2 | O=4 |charge=2+\n| molecular_weight = 414.538 g/mol\n| smiles = [Br-].[Br-].OC1(OCC[N+](C)(C)C1)c2ccc(cc2)c3ccc(cc3)C4(O)OCC[N+](C)(C)C4\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C24H34N2O4.2BrH/c1-25(2)13-15-29-23(27,17-25)21-9-5-19(6-10-21)20-7-11-22(12-8-20)24(28)18-26(3,4)14-16-30-24;;/h5-12,27-28H,13-18H2,1-4H3;2*1H/q+2;;/p-2\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = OPYKHUMNFAMIBL-UHFFFAOYSA-L\n| synonyms = <small>2-[4-[4-(2-hydroxy-4,4-dimethylmorpholin-4-ium-2-yl)phenyl]phenyl]-4,4-dimethylmorpholin-4-ium-2-ol</small>\n}}\n\n'''Hemicholinium-3''' ('''HC3'''), also known as '''hemicholine''', is a [[drug]] which blocks the [[reuptake]] of [[choline]] by the high-affinity [[choline transporter]] (ChT; encoded in humans by the gene ''SLC5A7'') at the [[Chemical synapse|presynapse]]. The reuptake of choline is the [[rate-limiting step]] in the synthesis of [[acetylcholine]]; hence, hemicholinium-3 decreases the synthesis of acetylcholine. It is therefore classified as an [[Receptor antagonist|indirect]] [[acetylcholine antagonist]].<ref name=\"Carlson\">{{cite book | first= Neil R. | last= Carlson | name-list-format = vanc | year= 2007 | title= Physiology of Behavior | edition=9th | location= Boston | publisher=Pearson Education, Inc. | isbn= 0-205-46724-5 | page= 117}}</ref>\n\nAcetylcholine is synthesized from choline and a donated [[acetyl]] group from [[acetyl-CoA]], by the action of [[choline acetyltransferase]] (ChAT). Thus, decreasing the amount of choline available to a neuron will decrease the amount of acetylcholine produced. Neurons affected by hemicholinium-3 must rely on the transport of choline from the [[Soma (biology)|soma]] (cell body), rather than relying on reuptake of choline from the synaptic cleft.\n\n==Toxicity==\nHemicholinium-3 is highly toxic because it interferes with cholinergic neurotransmission. The LD50 of hemicholinium-3 for mice is about 35 \u03bcg.<ref>{{cite journal | vauthors = Freeman JJ, Kosh JW, Parrish JS | title = Peripheral toxicity of hemicholinium-3 in mice | journal = British Journal of Pharmacology | volume = 77 | issue = 2 | pages = 239\u201344 | date = October 1982 | pmid = 7139185 | pmc = 2044599 | doi = 10.1111/j.1476-5381.1982.tb09291.x }}</ref>\n\n== See also ==\n*[[Triethylcholine]]\n*[[Vesamicol]]\n\n== References ==\n{{Reflist}}\n\n{{Acetylcholine metabolism and transport modulators}}\n\n[[Category:Lactols]]\n[[Category:Morpholines]]\n[[Category:Quaternary ammonium compounds]]\n[[Category:Acetylcholine synthesis inhibitors]]\n[[Category:Biphenyls]]\n", "text_old": "{{Redirect|HC-3|the United States Navy helicopter squadron designated HC-3 from 1967 to 2005|HCS-3}}\n{{Drugbox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 400103507\n| IUPAC_name = (2''S'',2''S'')-2,2'-biphenyl-4,4'-diyl''bis''(2-hydroxy-4,4-dimethylmorpholin-4-ium)\n| image = Hemicholinium-3.svg\n| alt = Skeletal formula\n| width = 260\n| image2 = Hemicholinium-3 cation spacefill.png\n| alt2 = Space-filling model of the hemicholinium-3 cation\n\n<!--Clinical data-->\n| tradename =  \n| legal_status =  \n| routes_of_administration =\n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =\n\n<!--Identifiers-->\n| IUPHAR_ligand = 4493\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 312-45-8\n| ATC_prefix = None\n| ATC_suffix =  \n| PubChem = 9399\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 9029\n| ChEMBL_Ref = {{ebicite|changed|EBI}}\n| ChEMBL = 268697\n\n<!--Chemical data-->\n| C=24 | H=34 | N=2 | O=4 |charge=2+\n| molecular_weight = 414.538 g/mol\n| smiles = [Br-].[Br-].OC1(OCC[N+](C)(C)C1)c2ccc(cc2)c3ccc(cc3)C4(O)OCC[N+](C)(C)C4\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C24H34N2O4.2BrH/c1-25(2)13-15-29-23(27,17-25)21-9-5-19(6-10-21)20-7-11-22(12-8-20)24(28)18-26(3,4)14-16-30-24;;/h5-12,27-28H,13-18H2,1-4H3;2*1H/q+2;;/p-2\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = OPYKHUMNFAMIBL-UHFFFAOYSA-L\n| synonyms = <small>2-[4-[4-(2-hydroxy-4,4-dimethylmorpholin-4-ium-2-yl)phenyl]phenyl]-4,4-dimethylmorpholin-4-ium-2-ol</small>\n}}\n\n'''Hemicholinium-3''' ('''HC3'''), also known as '''hemicholine''', is a [[drug]] which blocks the [[reuptake]] of [[choline]] by the high-affinity [[choline transporter]] (ChT; encoded in humans by the gene ''SLC5A7'') at the [[Chemical synapse|presynapse]]. The reuptake of choline is the [[rate-limiting step]] in the synthesis of [[acetylcholine]]; hence, hemicholinium-3 decreases the synthesis of acetylcholine. It is therefore classified as an [[Receptor antagonist|indirect]] [[acetylcholine antagonist]].<ref name=\"Carlson\">{{cite book | first= Neil R. | last= Carlson | name-list-format = vanc | year= 2007 | title= Physiology of Behavior | edition=9th | location= Boston | publisher=Pearson Education, Inc. | isbn= 0-205-46724-5 | page= 117}}</ref>\n\nAcetylcholine is synthesized from choline and a donated [[acetyl]] group from [[acetyl-CoA]], by the action of [[choline acetyltransferase]] (ChAT). Thus, decreasing the amount of choline available to a neuron will decrease the amount of acetylcholine produced. Neurons affected by hemicholinium-3 must rely on the transport of choline from the [[Soma (biology)|soma]] (cell body), rather than relying on reuptake of choline from the synaptic cleft.\n\n==Toxicity==\nHemicholinium-3 is highly toxic because it interferes with cholinergic neurotransmission. The LD50 of hemicholinium-3 for mice is about 35 \u03bcg.<ref>{{cite journal | vauthors = Freeman JJ, Kosh JW, Parrish JS | title = Peripheral toxicity of hemicholinium-3 in mice | journal = British Journal of Pharmacology | volume = 77 | issue = 2 | pages = 239\u201344 | date = October 1982 | pmid = 7139185 | pmc = 2044599 | doi = 10.1111/j.1476-5381.1982.tb09291.x }}</ref>\n\n== See also ==\n*[[Triethylcholine]]\n*[[Vesamicol]]\n\n== References ==\n{{Reflist}}\n\n{{Acetylcholine metabolism and transport modulators}}\n\n[[Category:Lactols]]\n[[Category:Morpholines]]\n[[Category:Quaternary ammonium compounds]]\n[[Category:Acetylcholine synthesis inhibitors]]\n[[Category:Biphenyls]]\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/Hemicholinium-3"}
